Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Maternal Death Due to Amniotic Fluid Embolism: A National Study in France

Bonnet, M.P.; Zlotnik, D.; Saucedo, M.; Chassard, D.; Bouvier-Colle, M.H.; Deneux-Tharaux, C.French National Experts Committee on Maternal Mortality

Obstetric Anesthesia Digest: June 2018 - Volume 38 - Issue 2 - p 63
doi: 10.1097/01.aoa.0000532252.38893.c1
Editorials and Reviews

(Anesth Analg. 2018;126(1):175–182)

Signs and symptoms of amniotic fluid embolism (AFE) vary greatly and are not specific to AFE, making it a difficult condition to diagnose and treat. Recently, the Society for Maternal-Fetal Medicine (SMFM) and the AFE Foundation proposed 4 uniform diagnostic criteria to help identify cases of AFE for research purposes. These criteria have not been tested on a specific population. The authors of the present study applied these criteria to maternal deaths attributed to AFE between 2007 and 2011, as identified by a national experts committee from the French Confidential Enquiry into Maternal Deaths, to evaluate its potential as a diagnostic tool. Furthermore, they described the epidemiology, clinical characteristics, and management of AFE by the presence or absence of all 4 diagnostic criteria.

Inserm UMR 1153 Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Centre for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in Pregnancy, Paris Descartes University, Paris, France; Anesthesia and Intensive Care Department, Cochin Hospital, University Hospitals Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris V University, Paris, France

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved